Jove
Visualize
Contact Us

Related Concept Videos

Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

202
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
202
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

220
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
220
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

208
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
208

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dopamine receptors in ocular surface biology: Current evidence and future directions.

Indian journal of ophthalmology·2026
Same author

Atropine reinstates inflammation-induced dysregulation of dopamine and its receptors in human scleral cells: Implications for myopia therapy.

Indian journal of ophthalmology·2026
Same author

Long-term Outcomes of the Management of Chronic Refractory Ocular Allergy Using Allergen Immunotherapy.

Cornea·2026
Same author

Immunological Interplay at the Ocular Surface of Stevens-Johnson Syndrome, Ocular Cicatricial Pemphigoid, and Ocular Graft Versus Host Disease.

Investigative ophthalmology & visual science·2026
Same author

Biological cleansing: Toward improving ocular surface surgical outcomes.

Indian journal of ophthalmology·2026
Same author

Sesamol reprograms mitochondrial dysfunction and metabolic signaling to rescue endothelial degeneration in Fuchs' endothelial corneal dystrophy.

Free radical biology & medicine·2026
Same journal

Evaluation of the Toxicity and Efficacy of an Adeno-Associated Viral Vector Expressing <i>BEST1</i> Delivered by Subretinal Injection in a Canine Model of Human Bestrophinopathy.

Human gene therapy·2026
Same journal

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

Human gene therapy·2026
Same journal

Genome Editing for Familial Hemophagocytic Lymphohistiocytosis: Design Principles, Challenges, and Translational Perspectives.

Human gene therapy·2026
Same journal

Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration.

Human gene therapy·2026
Same journal

Hyperthermia-Enhanced Adeno-Associated Virus Gene Therapy: Mechanisms, Delivery Technologies, and Translational Potential.

Human gene therapy·2026
Same journal

Adeno-Associated Virus Gene Therapy Translation: Lessons from Early Regulatory Meetings.

Human gene therapy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 10, 2026

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
09:28

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation

Published on: May 18, 2020

9.2K

Multivariate Process Optimization for Fixed-Bed Bioreactor-Based AAV Production Improves Total Batch Yield.

Ruchita Selot1, Ashish Khaparde1, Sharath Babu G R1

  • 1GROW Research Laboratory, Narayana Netralaya Foundation, Bengaluru, India.

Human Gene Therapy
|November 24, 2025
PubMed
Summary
This summary is machine-generated.

Optimizing fixed-bed bioreactor parameters significantly enhances adeno-associated viral vector (AAV) production. This study achieved a 7.6-fold increase in viral yield, paving the way for scalable gene therapy manufacturing.

Keywords:
adeno-associated virus (AAV)fixed-bed bioreactorgenomic titerprocess developmenttransient transfectiontriple plasmid system

More Related Videos

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.6K
Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System
10:31

Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System

Published on: January 13, 2022

10.2K

Related Experiment Videos

Last Updated: Jan 10, 2026

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
09:28

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation

Published on: May 18, 2020

9.2K
Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.6K
Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System
10:31

Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System

Published on: January 13, 2022

10.2K

Area of Science:

  • Biotechnology
  • Gene Therapy
  • Bioprocessing

Background:

  • Adeno-associated viral vectors (AAVs) are critical for gene therapy but face production scalability challenges.
  • High-quality, high-yield AAV production is essential for clinical applications.

Purpose of the Study:

  • To optimize adeno-associated viral vector (AAV) production in a fixed-bed bioreactor.
  • To enhance AAV yield and scalability for gene therapy applications.

Main Methods:

  • Systematic optimization of cell seeding density, transfection density, and DNA-to-cell ratio in a fixed-bed bioreactor.
  • Utilized transient transfection in adherent HEK-293T cells, packaging reporter and therapeutic genes into AAV9 capsids.
  • Monitored key bioreactor parameters (pH, dissolved oxygen, glucose) over a 10-day production cycle.

Main Results:

  • Achieved cell densities up to 3 × 10^9 cells/m^2 in the fixed-bed bioreactor.
  • Increased viral yield by approximately 7.6-fold compared to the prototype batch.
  • Attained an average AAV vector yield of 2.3 × 10^14 vg, with an average per-cell yield of 1.4 × 10^5 vg/cell.

Conclusions:

  • Optimizing process parameters in fixed-bed bioreactors is a viable strategy for scalable AAV production.
  • This approach offers a promising route for cost-effective manufacturing of AAV vectors for clinical trials.
  • The optimized process supports high cell densities and significantly boosts viral yield.